Attributes | Values |
---|
rdf:type
| |
description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2010 (ast)
- наукова стаття, опублікована в травні 2010 (uk)
- scientific article published on May 2010 (en)
- مقالة علمية نشرت في مايو 2010 (ar)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - Stephen Kaptoge
- Sebhat Erqou
- Alexander Thompson
|
rdfs:label
| - Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (en)
- Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (nl)
- Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (ast)
|
skos:prefLabel
| - Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (en)
- Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (nl)
- Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (ast)
|
name
| - Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (en)
- Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (nl)
- Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (ast)
|
author
| |
author
| |
title
| |
title
| - Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/J.JACC.2009.10.080
|
ResearchGate publication ID
| |
ResearchGate publication ID
| |
is about
of | |
is cites work
of | - Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).
- Lipoprotein(a) as a cardiovascular risk factor: current status
- Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review
- Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk
- Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials
- Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice
- Lipoprotein(a): resurrected by genetics
- Screening for and management of elevated Lp(a).
- Causes and consequences of lipoprotein(a) abnormalities in kidney disease
- Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
- Dyslipidemia in women with polycystic ovary syndrome
- Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study
- Antisense technology: an emerging platform for cardiovascular disease therapeutics
- Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis
- Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?
- Lipoprotein (a): Coming of Age at Last
- Structure, function, and genetics of lipoprotein (a).
- Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
- Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies
- Lipid parameters for measuring risk of cardiovascular disease
- Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome
- The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab
- Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy
- Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles
|